$5.60
0.00 (0%)
Indevus Pharmaceuticals (NASDAQ:IDEV.DL)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.
RSS Headlines
Fool UK